Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Low Body Weight Patients with Atrial Fibrillation: A Systematic Review and Meta-analysis
MN Elshafei, M Salem, A El-Bardissy… - … Drugs and Therapy, 2024 - Springer
Introduction Direct oral anticoagulant (DOAC) agents are established as the anticoagulation
strategy of choice for a variety of clinical risks. Despite this, uncertainty still exists with regard …
strategy of choice for a variety of clinical risks. Despite this, uncertainty still exists with regard …
Evaluation of Apixaban standard dosing in underweight patients with non-valvular atrial fibrillation: a retrospective cohort study
Background Recent guidelines recommend using direct oral anticoagulants (DOACs) as first-
line agents in patients with non-valvular atrial fibrillation (NVAF). Research is currently …
line agents in patients with non-valvular atrial fibrillation (NVAF). Research is currently …
Phenotype-directed clinically driven low-dose direct oral anticoagulant for atrial fibrillation
TW Kao, PJ Liao - Future Cardiology, 2023 - Taylor & Francis
Clinically-driven dose reduction of direct oral anticoagulants in individuals with atrial
fibrillation is prevalent worldwide. However, a paucity of evidence to tailor dose selection …
fibrillation is prevalent worldwide. However, a paucity of evidence to tailor dose selection …